Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2012 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Danger Ahead: The Growing Safety Challenges
By Patrick M. Schmidt
Features
Proactive Screenings for Women’s Health
By
Trudie Mitschang
The Drug Shortage Crisis
By
Ronale Tucker Rhodes, MS
Myths and Facts: Heart Disease
By
Ronale Tucker Rhodes, MS
Risky Business
By
Trudie Mitschang
The Growing Threat of Counterfeit Drugs
By
Ronale Tucker Rhodes, MS
Lifelong Need for IG? Weighing the Pros and Cons
By
Show No Author
BioTrends Watch
Washington Report
Initiatives to Lower Medicaid Costs and Improve Care
New Rule Requires Plain Language in Describing Health Plan Benefits and Coverage
Partnership for Patients Meeting Participant Goal
Court Rules for NIH in Stem Cell Research
New Rules Simplify Healthcare Paperwork
Reimbursement FAQs
Reimbursement FAQs
Industry News
FDA Approves Advate to Treat Hemophilia A
2012 Vaccine Schedule for Children Is Released
UNICEF Lists Vaccine Prices to Drive Down Cost
U.S. Sets New Goals for a Healthier Nation
Google Invests in Counterfeit Drug Fighting Technology
Combined IVIG Treatment Effective to Treat Kawasaki Disease
FDA Approves Pneumococcal Vaccine for Adults 50-Plus
Povidine Iodine Prep Pads Are Voluntarily Recalled
FDA Approves Supplemental Test for Chagas Disease
FDA Approves First Quadrivalent Flu Vaccine
Immunotherapy May Help to Treat Alzheimer’s
More Evidence of an Autism Immune Component
Albumin Can Be Grown in Rice
People with Job's Syndrome Have Impaired Immune Memory
Clinical Trials Update
BioFocus
Industry Insight
Human Plasma Products: Two Decades of Unsurpassed Safety
By Keith Berman, MPH, MBA
Patient Profile
Life Interrupted
By Trudie Mitschang
BioSources
BioResearch
Over Half of U.S. Hemophilia Treatment Centers Do Not Follow NHF Guidelines for Factor VIII Prophylaxis in Severe Hemophilia A
Inhibitors Don’t Differ for Previously Untreated Patients Given Plasma-Derived and Recombinant Factor VIII: Systematic Review
Trend Toward Better Responses in Subarachnoid Hemorrhage Patients Treated with 25% Human Albumin: Pilot Study